Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992676 · ClinicalTrials.gov registry record
Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation
A clinical trial of Coronary Artery Disease and Sleep Disorder; Breathing-Related, sponsored by Mayo Clinic.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT04992676: Completed study of Coronary Artery Disease and Sleep Disorder; Breathing-Related, sponsored by Mayo Clinic.
NCT04992676 is a study of Coronary Artery Disease and Sleep Disorder; Breathing-Related that has completed, run by Mayo Clinic. The registered enrollment target is 43 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04992676, a study of Coronary Artery Disease and Sleep Disorder; Breathing-Related, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine how frequently sleep disorders such as sleep disordered breathing and insomnia occur in patients with coronary artery disease enrolled in cardiac rehabilitation. By reviewing results of a variety of tests, we also hope to learn more about the cardiovascular effects on people who may have these conditions.
Primary Outcome
Comorbid SDB and insomnia will be highly prevalent (\>30%) in this population. Measured by home, overnight polysomnography
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Polysomnograpy
- DIAGNOSTIC_TEST actigraphy
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2024-05-02 |
What the finished NCT04992676 record still lists
NCT04992676 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Polysomnograpy is the first listed.
NCT04992676 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04992676 about?
NCT04992676 is a clinical study titled "Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation". The purpose of this research is to determine how frequently sleep disorders such as sleep disordered breathing and insomnia occur in patients with coronary artery disease enrolled in cardiac rehabilitation. By reviewing results of a variety of tests, we also hope to learn more about the cardiovascul...
What is the current status of trial NCT04992676?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-08-19. Estimated completion is 2024-05-02.
What conditions does trial NCT04992676 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Sleep Disorder; Breathing-Related, Sleep Disorder; Insomnia Type.
What interventions are being tested in trial NCT04992676?
The interventions under investigation include: Polysomnograpy (DIAGNOSTIC_TEST), actigraphy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04992676?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04992676 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04992676's enrollment target sits among peer trials
43 186th of 219 higher than 34 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI